Evidence map›Paper›PMID 41585798›Full record

ReviewFrontiers in endocrinology2025

Exogenous insulin autoimmune syndrome: a case report and literature review.

Yingyi Gao, Nan Wang, Zhishan Huang, Ning Bai

Abstract readCase ReportsReview
In one paragraph

Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yingyi GaoWuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Nan WangWuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Zhishan HuangWuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Ning BaiDepartment of Endocrinology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exogenous Insulin Autoimmune Syndrome (EIAS) is a rare hypersensitivity reaction triggered by the administration of exogenous insulin. This reaction induces the production of insulin autoantibodies, leading to various clinical manifestations such as insulin resistance, hyperglycemia, recurrent hypoglycemic episodes, and allergic reactions. Due to limited clinical awareness, EIAS is often misdiagnosed or overlooked. Herein, we present a case of EIAS in a patient with type 2 diabetes mellitus, providing a detailed analysis of its clinical features, laboratory findings, differential diagnoses, therapeutic approaches, and clinical outcomes, supplemented by a literature review. This report aims to enhance clinicians' diagnostic and therapeutic proficiency in managing this condition.

Indexed as

Autoimmune DiseasesDiabetes Mellitus, Type 2Hypoglycemic AgentsInsulinAutoantibodiesFemaleHumansMaleMiddle AgedSyndromeAutoantibodiesHypoglycemic AgentsInsulinexogenous insulinHLA-DR4hyperinsulinemic hypoglycemiainsulin autoantibodyinsulin autoimmune syndrome

Identifiers

PMID41585798
PMCPMC12827137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.